Dual inhibition of cannabinoid CB(1) receptor and inducible NOS attenuates obesity‐induced chronic kidney disease

BACKGROUND AND PURPOSE: Obesity, an important risk factor for developing chronic kidney disease (CKD), affects the kidneys by two main molecular signalling pathways: the endocannabinoid/CB(1) receptor system, whose activation in obesity promotes renal inflammation, fibrosis, and injury, and the indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Udi, Shiran, Hinden, Liad, Ahmad, Majdoleen, Drori, Adi, Iyer, Malliga R., Cinar, Resat, Herman‐Edelstein, Michal, Tam, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976880/
https://www.ncbi.nlm.nih.gov/pubmed/31454063
http://dx.doi.org/10.1111/bph.14849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976880/
https://www.ncbi.nlm.nih.gov/pubmed/31454063
http://dx.doi.org/10.1111/bph.14849

Ejemplares similares